Boomfish Wealth Group LLC Reduces Position in UnitedHealth Group Incorporated (NYSE:UNH)

Boomfish Wealth Group LLC cut its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 4.5% during the 3rd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 4,567 shares of the healthcare conglomerate’s stock after selling 217 shares during the period. UnitedHealth Group comprises about 1.6% of Boomfish Wealth Group LLC’s investment portfolio, making the stock its 19th biggest position. Boomfish Wealth Group LLC’s holdings in UnitedHealth Group were worth $2,670,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Kathleen S. Wright Associates Inc. bought a new stake in UnitedHealth Group during the third quarter valued at about $27,000. Macroview Investment Management LLC raised its stake in UnitedHealth Group by 671.4% during the 2nd quarter. Macroview Investment Management LLC now owns 54 shares of the healthcare conglomerate’s stock valued at $28,000 after purchasing an additional 47 shares during the period. Delos Wealth Advisors LLC boosted its stake in UnitedHealth Group by 757.1% in the 1st quarter. Delos Wealth Advisors LLC now owns 60 shares of the healthcare conglomerate’s stock worth $30,000 after purchasing an additional 53 shares during the period. Bbjs Financial Advisors LLC bought a new stake in shares of UnitedHealth Group during the second quarter valued at approximately $31,000. Finally, Global Wealth Strategies & Associates grew its stake in UnitedHealth Group by 152.4% during the third quarter. Global Wealth Strategies & Associates now owns 53 shares of the healthcare conglomerate’s stock valued at $31,000 after acquiring an additional 32 shares in the last quarter. Hedge funds and other institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Stock Up 1.6 %

NYSE:UNH opened at $607.55 on Tuesday. The stock has a fifty day simple moving average of $584.39 and a 200-day simple moving average of $532.15. The company has a current ratio of 0.88, a quick ratio of 0.88 and a debt-to-equity ratio of 0.67. The company has a market cap of $561.02 billion, a price-to-earnings ratio of 40.29, a price-to-earnings-growth ratio of 1.66 and a beta of 0.58. UnitedHealth Group Incorporated has a twelve month low of $436.38 and a twelve month high of $608.63.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Tuesday, July 16th. The healthcare conglomerate reported $6.80 EPS for the quarter, topping analysts’ consensus estimates of $6.66 by $0.14. UnitedHealth Group had a net margin of 3.66% and a return on equity of 26.55%. The business had revenue of $98.86 billion for the quarter, compared to the consensus estimate of $98.73 billion. During the same period in the prior year, the firm earned $6.14 EPS. The company’s revenue for the quarter was up 6.4% compared to the same quarter last year. Analysts anticipate that UnitedHealth Group Incorporated will post 27.69 EPS for the current year.

UnitedHealth Group Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Tuesday, September 24th. Stockholders of record on Monday, September 16th were given a dividend of $2.10 per share. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.38%. The ex-dividend date was Monday, September 16th. UnitedHealth Group’s payout ratio is 55.70%.

Analyst Ratings Changes

Several research analysts have commented on UNH shares. TD Cowen raised their price objective on UnitedHealth Group from $546.00 to $601.00 and gave the company a “buy” rating in a research report on Wednesday, July 17th. Morgan Stanley lifted their price objective on UnitedHealth Group from $595.00 to $615.00 and gave the stock an “overweight” rating in a research note on Wednesday, July 17th. Cantor Fitzgerald reiterated an “overweight” rating and set a $591.00 target price on shares of UnitedHealth Group in a research report on Tuesday, October 1st. Truist Financial upped their price target on shares of UnitedHealth Group from $600.00 to $640.00 and gave the company a “buy” rating in a research note on Wednesday, July 17th. Finally, Wells Fargo & Company boosted their target price on shares of UnitedHealth Group from $525.00 to $630.00 and gave the stock an “overweight” rating in a report on Wednesday, July 17th. Two research analysts have rated the stock with a hold rating, eighteen have given a buy rating and two have issued a strong buy rating to the company. According to MarketBeat, UnitedHealth Group currently has a consensus rating of “Buy” and an average price target of $617.37.

Insider Buying and Selling

In other news, CAO Thomas E. Roos sold 2,851 shares of the business’s stock in a transaction dated Wednesday, July 17th. The shares were sold at an average price of $569.88, for a total value of $1,624,727.88. Following the completion of the sale, the chief accounting officer now owns 29,501 shares in the company, valued at approximately $16,812,029.88. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. In other news, CAO Thomas E. Roos sold 2,851 shares of the business’s stock in a transaction on Wednesday, July 17th. The stock was sold at an average price of $569.88, for a total value of $1,624,727.88. Following the completion of the transaction, the chief accounting officer now directly owns 29,501 shares of the company’s stock, valued at approximately $16,812,029.88. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, EVP Erin Mcsweeney sold 1,500 shares of UnitedHealth Group stock in a transaction dated Thursday, July 18th. The shares were sold at an average price of $579.03, for a total value of $868,545.00. Following the completion of the transaction, the executive vice president now owns 7,785 shares in the company, valued at $4,507,748.55. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. 0.33% of the stock is owned by insiders.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.